161 – 170 of 327
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Effects on the glucagon response to hypoglycaemia during DPP-4 inhibition in elderly subjects with type 2 diabetes : A randomized, placebo-controlled study
- Contribution to journal › Article
-
Mark
Overweight, obesity and the risk of LADA : results from a Swedish case–control study and the Norwegian HUNT Study
- Contribution to journal › Article
-
Mark
DPP-4 is expressed in human pancreatic beta cells and its direct inhibition improves beta cell function and survival in type 2 diabetes
- Contribution to journal › Article
-
Mark
Effect of single-dose DPP-4 inhibitor sitagliptin on β-cell function and incretin hormone secretion after meal ingestion in healthy volunteers and drug-naïve, well-controlled type 2 diabetes subjects
- Contribution to journal › Article
-
Mark
Valuing a Lifestyle Intervention for Middle Eastern Immigrants at Risk of Diabetes
- Contribution to journal › Article
-
Mark
Increased plasma brain-derived neurotrophic factor 10.5 h after intake of whole grain rye-based products in healthy subjects
- Contribution to journal › Article
-
Mark
MC1568 improves insulin secretion in islets from type 2 diabetes patients and rescues β-cell dysfunction caused by Hdac7 upregulation
- Contribution to journal › Article
-
Mark
DNA methylation in the pathogenesis of type 2 diabetes in humans
- Contribution to journal › Scientific review
-
Mark
Impact of a multifactorial treatment programme on clinical outcomes and cardiovascular risk estimates : A retrospective cohort study from a specialised diabetes centre in Denmark
- Contribution to journal › Article
-
Mark
Different glucagon effects during DPP-4 inhibition versus SGLT-2 inhibition in metformin-treated type 2 diabetes patients
- Contribution to journal › Article
